Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis

Journal of Pathology

Volumn 240, Issue 2, 2016, Pages 197-210

  Shimbori, Chiko ^a   Bellaye, Pierre Simon ^a   Xia, Jiaji ^a   Gauldie, Jack ^b   Ask, Kjetil ^a,b   Ramos, Carlos ^c   Becerril, Carina ^c   Pardo, Annie ^d   Selman, Moises ^c   Kolb, Martin ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

caveolin 1; FGF 1; FGFR; pulmonary fibrosis; TGF 1; TGF R1

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SMOOTH MUSCLE ACTIN; ALPHA TUBULIN; CAVEOLIN 1; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MESSENGER RNA; PROTEASOME; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM CELL; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG PARENCHYMA; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; THERAPY EFFECT;

EID: 84988643127     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4768     Document Type: Article

References (49)

1. Richeldi L, du Bois RM, Raghu G, et al. INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071–2082.
2. King TE Jr, Bradford WZ, Castro-Bernardini S, et al. ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083–2092.
3. Duffield JS, Lupher M, Thannickal VJ, et al. Host responses in tissue repair and fibrosis. Annu Rev Pathol 2013; 8: 241–276.
4. Maharaj S, Shimbori C, Kolb M. Fibrocytes in pulmonary fibrosis: a brief synopsis. Eur Respir Rev 2013; 22: 552–557.
5. Hambly N, Shimbori C, Kolb M. Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers. Respirology 2015; 20: 1010–1022.
6. Selman M, Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res 2002; 3: 3.
7. Selman M, Pardo A. Alveolar epithelial cell disintegrity and subsequent activation: a key process in pulmonary fibrosis. Am J Respir Crit Care Med 2012; 186: 119–121.
8. Selman M, Pardo A. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model. Am J Respir Crit Care Med 2014; 189: 1161–1172.
9. Xu X, Dai H, Wang C. Epithelium dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions. Clin Respir J 2016; 10: 133–141.
10. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc 2006; 3: 364–372.
11. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature Med 2012; 18: 1028–1040.
12. Itoh N, Ornitz DM. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 2011; 149: 121–130.
13. Gospodarowicz D, Moran JS. Stimulation of division of sparse and confluent 3 T3 cell populations by a fibroblast growth factor, dexamethasone, and insulin. Proc Natl Acad Sci U S A 1974; 71: 4584–4588.
14. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001;2: REVIEWS3005.
15. Sannes PL, Burch KK, Khosla J. Immunohistochemical localization of epidermal growth factor and acidic and basic fibroblast growth factors in postnatal developing and adult rat lungs. Am J Respir Cell Mol Biol 1992; 7: 230–237.
16. Ornitz DM, Xu J, Colvin JS, et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996; 271: 15292–15297.
17. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005; 16: 139–149.
18. Zhang X, Ibrahimi OA, Olsen SK, et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 2006; 281: 15694–15700.
19. Armelin HA. Pituitary extracts and steroid hormones in the control of 3 T3 cell growth. Proc Natl Acad Sci U S A 1973; 70: 2702–2706.
20. Barrios R, Pardo A, Ramos C, et al. Upregulation of acidic fibroblast growth factor during development of experimental lung fibrosis. Am J Physiol 1997; 273: L451-L458.
21. MacKenzie B, Korfei M, Henneke I, et al. Increased FGF1–FGFRc expression in idiopathic pulmonary fibrosis. Respir Res 2015; 16: 83.
22. Becerril C, Pardo A, Montaño M, et al. Acidic fibroblast growth factor induces an antifibrogenic phenotype in human lung fibroblasts. Am J Respir Cell Mol Biol 1999; 20: 1020–1027.
23. Ramos C, Montaño M, Becerril C, et al. Acidic fibroblast growth factor decreases alpha smooth muscle actin expression and induces apoptosis in human normal lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2006; 291: L871-L879.
24. Ramos C, Becerril C, Montaño M, et al. FGF1 reverts epithelial mesenchymal transition induced by TGF-β1 through MAPK/ERK kinase pathway. Am J Physiol Lung Cell Mol Physiol 2010; 299: L222-L231.
25. Leslie CC, McCormick-Shannon K, Robinson PC, et al. Stimulation of DNA synthesis in cultured rat alveolar type II cells. Exp Lung Res 1985; 8: 53–66.
26. Leslie CC, McCormick-Shannon K, Mason RJ. Heparin binding growth factors stimulate DNA synthesis in rat alveolar type II cells. Am J Respir Cell Mol Biol 1990; 2: 99–106.
27. Leslie CC, McCormick-Shannon K, Shannon JM, et al. Heparin-binding EGF-like growth factor is a mitogen for rat alveolar type II cells. Am J Respir Cell Mol Biol 1997; 16: 379–387.
28. Louzier V, Raoul W, Leroux A, et al. Adenovirus-mediated fibroblast growth factor 1 expression in the lung induces epithelial cell proliferation: consequences to hyperoxic lung injury in rats. Hum Gene Ther 2004; 15: 793–804.
29. Rosenbloom J, Castro SV, Jimenez SA. Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann Intern Med 2010; 152: 159–166.
30. Feng L, Liao WX, Luo Q, et al. Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae. J Cell Physiol 2012; 227: 2480–2491.
31. Palmer DJ, Ng P. Methods for the production of first generation adenoviral vectors. Methods Mol Biol 2008; 433: 55–78.
32. Sime PJ, Xing Z, Graham FL, et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100: 768–776.
33. Farkas L, Farkas D, Gauldie J, et al. Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs. Am J Respir Cell Mol Biol 2011; 44: 870–878.
34. Ask K, Bonniaud P, Maass K, et al. Progressive pulmonary fibrosis is mediated by TGF-β isoform 1 but not TGF-β3. Int J Biochem Cell Biol 2008; 40: 484–495.
35. Pan T, Mason RJ, Westcott JY, et al. Rat alveolar type II cells inhibit lung fibroblast proliferation in vitro. Am J Respir Cell Mol Biol 2001; 25: 353–361.
36. Lama V, Moore BB, Christensen P, et al. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase2-dependent. Am J Respir Cell Mol Biol 2002; 27: 752–758.
37. Kohyama T, Ertl RF, Valenti V, et al. Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1257-L1263.
38. Shimbori C, Gauldie J, Kolb M. Extracellular matrix microenvironment contributes actively to pulmonary fibrosis. Curr Opin Pulm Med 2013; 19: 446–452.
39. Lönn P, Morén A, Raja E, et al. Regulating the stability of TGFβ receptors and Smads. Cell Res 2009; 19: 213–215.
40. Chen YG. Endocytic regulation of TGF-β signaling. Cell Res 2009; 19: 58–70.
41. Hwangbo C, Tae N, Lee S, et al. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization. Oncogene 2016; 35: 389–401.
42. Bergeron A, Soler P, Kambouchner M, et al. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-β and IL-10. Eur Respir J 2003; 22: 69–76.
43. Yu G, Kovkarova-Naumovski E, Jara P, et al. Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans. Am J Respir Crit Care Med 2012; 186: 752–762.
44. Kranenburg AR, De Boer WI, Van Krieken JH, et al. Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 27: 517–525.
45. Kranenburg AR, Willems-Widyastuti A, Mooi WJ, et al. Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1. J Pathol 2005; 206: 28–38.
46. Mignatti P, Morimoto T, Rifkin DB. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum–Golgi complex. J Cell Physiol 1992; 151: 81–93.
47. Sugahara K, Iyama K, Kuroda MJ, et al. Double intratracheal instillation of keratinocyte growth factor prevents bleomycin-induced lung fibrosis in rats. J Pathol 1998; 186: 90–98.
48. Gupte VV, Ramasamy SK, Reddy R, et al. Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 2009; 180: 424–436.
49. Jordana M, Schulman J, McSharry C, et al. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 1988; 137: 579–584.